Authors: Heyliger, SO Ni, Q Rothman, RB

Citation: So. Heyliger et al., Resolution of two [S-35]GTP-gamma-S binding sites and their response to chronic morphine treatment: A binding surface analysis, BRAIN RES B, 51(4), 2000, pp. 357-362

Authors: Hulet, SW Heyliger, SO Powers, S Conner, JR

Citation: Sw. Hulet et al., Oligodendrocyte progenitor cells internalize ferritin via clathrin-dependent receptor mediated endocytosis, J NEUROSC R, 61(1), 2000, pp. 52-60

Authors: Heyliger, SO Jackson, C Rice, KC Rothman, RB

Citation: So. Heyliger et al., Opioid peptide receptor studies. 10. Nor-BNI differentially inhibits kappareceptor agonist-induced G-protein activation in the guinea pig caudate: Further evidence of kappa receptor heterogeneity, SYNAPSE, 34(4), 1999, pp. 256-265

Authors: Romero, DV Partilla, JS Zheng, QX Heyliger, SO Ni, Q Rice, KC Lai, J Rothman, RB

Citation: Dv. Romero et al., Opioid peptide receptor studies. 12. Buprenorphine is a potent and selective mu/kappa antagonist in the [S-35]-GTP-gamma-S functional binding assay, SYNAPSE, 34(2), 1999, pp. 83-94

Authors: Heyliger, SO Mazzio, EA Soliman, KFA

Citation: So. Heyliger et al., The anti-inflammatory effects of quinolinic acid in the rat, LIFE SCI, 64(14), 1999, pp. 1177-1187